688767 logo

Hangzhou Biotest Biotech Co.,Ltd. Stock Price

SHSE:688767 Community·CN¥4.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

688767 Share Price Performance

CN¥30.81
7.79 (33.83%)
CN¥30.81
7.79 (33.83%)
Price CN¥30.81

688767 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks
0 Rewards

Hangzhou Biotest Biotech Co.,Ltd. Key Details

CN¥448.4m

Revenue

CN¥0

Cost of Revenue

CN¥448.4m

Gross Profit

CN¥401.6m

Other Expenses

CN¥46.8m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Apr 25, 2026
0.32
100.00%
10.44%
0.008%
View Full Analysis

About 688767

Founded
2008
Employees
622
CEO
Shujiang Wu
WebsiteView website
www.biotests.com.cn

Hangzhou Biotest Biotech Co.,Ltd. engages in the research and development, manufacture, sale, and service of in vitro diagnostic assays and reagents, and instruments in China and internationally. The company offers medical test products for fertility health, cardiology, oncology, inflammation, biochemistry, and various infectious diseases. It also provides veterinary test kits; fluorescence immunoassay rapid test kits; and other rapid testing kits. In addition, the company is widely utilized across various medical institutions, judicial testing systems, third-party testing organizations, Centers for Disease Control and Prevention (CDC), and private clinics. The company was founded in 2008 and is based in Hangzhou, China.

Recent 688767 News & Updates

Recent updates

No updates